1. Home
  2. KORE vs CELU Comparison

KORE vs CELU Comparison

Compare KORE & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KORE
  • CELU
  • Stock Information
  • Founded
  • KORE 2003
  • CELU 2016
  • Country
  • KORE United States
  • CELU United States
  • Employees
  • KORE N/A
  • CELU N/A
  • Industry
  • KORE Telecommunications Equipment
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • KORE Consumer Discretionary
  • CELU Health Care
  • Exchange
  • KORE Nasdaq
  • CELU Nasdaq
  • Market Cap
  • KORE 39.3M
  • CELU 42.2M
  • IPO Year
  • KORE N/A
  • CELU N/A
  • Fundamental
  • Price
  • KORE $2.35
  • CELU $1.94
  • Analyst Decision
  • KORE Hold
  • CELU
  • Analyst Count
  • KORE 2
  • CELU 0
  • Target Price
  • KORE $2.75
  • CELU N/A
  • AVG Volume (30 Days)
  • KORE 14.4K
  • CELU 73.1K
  • Earning Date
  • KORE 08-14-2025
  • CELU 05-08-2025
  • Dividend Yield
  • KORE N/A
  • CELU N/A
  • EPS Growth
  • KORE N/A
  • CELU N/A
  • EPS
  • KORE N/A
  • CELU N/A
  • Revenue
  • KORE $282,254,000.00
  • CELU $54,220,000.00
  • Revenue This Year
  • KORE $4.66
  • CELU $23.29
  • Revenue Next Year
  • KORE $6.71
  • CELU N/A
  • P/E Ratio
  • KORE N/A
  • CELU N/A
  • Revenue Growth
  • KORE N/A
  • CELU 138.11
  • 52 Week Low
  • KORE $1.10
  • CELU $1.00
  • 52 Week High
  • KORE $4.88
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • KORE 47.41
  • CELU 49.61
  • Support Level
  • KORE $2.20
  • CELU $1.80
  • Resistance Level
  • KORE $2.50
  • CELU $2.17
  • Average True Range (ATR)
  • KORE 0.18
  • CELU 0.18
  • MACD
  • KORE -0.02
  • CELU -0.01
  • Stochastic Oscillator
  • KORE 47.76
  • CELU 42.48

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: